2020
DOI: 10.1080/15265161.2020.1795538
|View full text |Cite
|
Sign up to set email alerts
|

Allocating Remdesivir Under Scarcity: Social Justice or More Systemic Racism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 5 publications
0
4
0
Order By: Relevance
“…The drug approval process and the legal nature of drug use varies internationally ( Box 1 ). For example, hydroxychloroquine, remdesivir and COVID-19 convalescent plasma had an emergency use authorization in the United States [ 13 , 14 , 15 ]. In other countries, these drugs have been given off-label uses or compassionate uses.…”
Section: Results Of the Ethical Analysismentioning
confidence: 99%
See 2 more Smart Citations
“…The drug approval process and the legal nature of drug use varies internationally ( Box 1 ). For example, hydroxychloroquine, remdesivir and COVID-19 convalescent plasma had an emergency use authorization in the United States [ 13 , 14 , 15 ]. In other countries, these drugs have been given off-label uses or compassionate uses.…”
Section: Results Of the Ethical Analysismentioning
confidence: 99%
“…In the United States, remdesivir obtained emergency use authorization on 1 May 2020, based on preliminary study results [ 37 ]. The actual benefit of remdesivir is so far an open question [ 15 ], as the drug has not gone through the usual safety and efficacy review process that is normally required before a drug is approved.…”
Section: Results Of the Ethical Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…As preventable deaths collected in migrant detention centers, prisons (Frois 2020) and care institutions (Cohen 2020), connections between biomedical and carceral regimes became clearer (Chua 2016;Terry 2017;Varma 2020). 8 The pandemic has yielded treatment inequities and exclusions, forms of medical experimentation on formerly colonized populations in the Global South (Bajaj and Stanford 2021, 1; The Straits Times 2020), new techniques of racialized surveillance, 9 and potentially risky relaxations in ethical guidelines around clinical trials, therapeutics, patient triaging, and resource allocations (see Ezekiel 2020;Goold 2020;Maguire 2020;Varma, Vora, Fox, Berkhout and Benmarhnia, 2021;Warren et al 2020;Weber and Bliton 2020). Covid-19 has also reignited fears about nosocomial-or hospital-borne-infections, as healthcare providers and patients alike worry about becoming vectors of community spread.…”
Section: Racialized Iatrogenesismentioning
confidence: 99%